
Dimitrios Farmakiotis
@DFarmakiotis
Followers
37
Following
25
Media
3
Statuses
44
Joined October 2020
RT @ABsteward: 🆕️🔥The largest real-world, multicenter study of dalbavancin use for Gram-positive BSI @NicholasRebold @IDpharmresearch and m….
link.springer.com
Infectious Diseases and Therapy - Long-acting lipoglycopeptides such as dalbavancin may have utility in patients with Gram-positive bloodstream infections (BSI), particularly in those with barriers...
0
46
0
Second published case (tok) of TOA abscess caused by #Ureaplasma, first (tok) diagnosed by #Karius_test, #cfDNA in plasma. @noufkmag @BrownIDprogram @KariusInc @sharmaphrm
mdpi.com
Genital mycoplasmas are sexually transmitted Mollicutes with a high prevalence of urogenital tract colonization among females of reproductive age. Current guidelines recommend against routine...
0
0
4
Promising results from our investigator-initiated prospective study of a commercially available CMV T-cell immunity assay! @noufkmag, @BrownIDprogram, @eurofinsviracor
0
2
7
RT @AnnaApostolopo3: Time to challenge the dogma of steroids for severe PJP? Our multicenter retrospective study of PJP in SOTRs led by Drs….
0
14
0
RT @eurofinsviracor: 📣 Webinar ALERT! Thursday, Nov. 16th. 1pm EST. Register NOW for ‘A Paradigm of Precision Medicine: Clinical utilizatio….
0
7
0
RT @noufkmag: I was honored to present our research work under the lead of Dr. Farmakiotis @DFarmakiotis on the utility of CMV-specific T-c….
0
9
0
RT @noufkmag: Thrilled to represent our @BrownIDprogram at the @IDWeekmtg Special thanks to Dr @DFarmakiotis for his research mentorship &….
0
3
0
RT @MichaelGIsonMD: It was a huge honor to work on this important study - the RSV vaccine adds to our armamentarium to keep our older adult….
nejm.org
Respiratory syncytial virus (RSV) is an important cause of acute respiratory infection, lower respiratory tract disease, clinical complications, and death in older adults. There is currently no lic...
0
17
0
RT @weldeiry: Learning @BrownMedicine @BrownPhysicians medicine grand rounds on post-transplant lymphoproliferative disease, fatal pulmonar….
0
2
0
RT @DrChoueiri: Using @COVID19nCCC dataset, we show that Vaccination against COVID-19, especially with additional doses, is a fundamental s….
0
11
0
mRNA vaccination decreases COVID-19-associated morbidity and mortality among organ transplant recipients: a contemporary cohort study | Open Forum Infectious Diseases | Oxford Academic Vaccines work led by @BrownMedicine MS @BrownIDprogram
academic.oup.com
AbstractBackground. Organ transplant recipients (OTRs) are less protected from vaccination than immunocompetent hosts. Additional vaccine doses have shown
0
0
2
RT @OFIDJournal: mRNA vaccination decreases COVID-19-associated morbidity and mortality among organ transplant recipients: a contemporary c….
0
2
0
RT @COVID19nCCC: The COVID-19 and Cancer Consortium (CCC19) Publications: [7/15/22] #COVID19nCancer @COVID19nCCC #C….
0
7
0
IDSA COVID-19 OUTPATIENT TREATMENT GUIDELINES ROADMAP: High titer conv plasma for outpatient management of COVID-19 in the immunosuppressed @COVID19nCCC @mtmdphd
0
0
0
RT @COVID19nCCC: Map of Participating Institutions (N=126) - COVID-19 and Cancer Consortium (#CCC19) [Apr 20, 2022] .
0
2
0
Single‐center experience with nirmatrelvir/ritonavir in kidney transplant recipients on tacrolimus maintenance immunosuppression Important work on #Paxlovid drug drug interactions, again with @BrownMedicine #trainee contribution. @BrownIDprogram.
onlinelibrary.wiley.com
Click on the article title to read more.
0
0
1
RT @Chrislabaki1: 1/ Happy to share with you our work on oncology clinical trial disruption during the pandemic out @Annals_Oncology @myESM….
annalsofoncology.org
COVID-19 disproportionately impacted patients with cancer as a result of direct infection, and delays in diagnosis and therapy. Oncological clinical trials are resource-intensive endeavors that could...
0
11
0
COVID-19 Treatments for Nonhospitalized Patients via @JAMA_current part of @JAMANetwork @BrownIDprogram Cannot emphasize enough the importance of checking for DDI when considering #Paxlovid in immunocompromised patients: First do no harm!.
0
0
2